Navigation Links
New Technique to Identify Bacteria for Food Safety

Researchers at Purdue University have used a new technique to rapidly detect and precisely identify bacteria, including dangerous E. coli, without time-consuming// treatments usually required.

The technique, called desorption electrospray ionization, or DESI, could be used to create a new class of fast, accurate detectors for applications ranging from food safety to homeland security, said R. Graham Cooks, the Henry Bohn Hass Distinguished Professor of Chemistry in Purdue's College of Science.

Using a mass spectrometer to analyze bacteria and other microorganisms ordinarily takes several hours and requires that samples be specially treated and prepared in a lengthy series of steps. DESI eliminates the pretreatment steps, enabling researchers to take "fingerprints" of bacteria in less than a minute using a mass spectrometer.

"This is the first time we've been able to chemically analyze and accurately identify the type of bacteria using a mass spectrometer without any prior pretreatment within a matter of seconds," Cooks said.

New findings show how the Purdue researchers used the method to detect living, untreated bacteria, including E. coli and Salmonella typhimurium, both of which cause potentially fatal infections in humans.

"There is always an advantage to the analysis of living systems because the bacteria retain their original properties," Cooks said.

The findings are detailed in a paper appearing in the journal Chemical Communications. The paper was written by chemistry graduate students Yishu Song, Nari Talaty and Zhengzheng Pan; Andy W. Tao, an assistant professor of biochemistry; and Cooks.

Mass spectrometry works by turning molecules into ions, or electrically charged versions of themselves, inside the instrument's vacuum chamber. Once ionized, the molecules can be more easily manipulated, detected and analyzed based on their masses. The key DESI innovation is performing the
'"/>




Page: 1 2 3

Related medicine news :

1. New Laser Techniques cure degeneration of the eye
2. New Technique to Study Infants Brain.
3. New Technique For Benign Breast Tumors
4. Preventing Strokes Using Less Invasive Techniques
5. New Technique To Detect Activity Of Drugs In The Body
6. New Technique To Test Stem Cells That Heal The Heart
7. A New Technique For Prediction Of Adult Height
8. Novel Technique For Targeting Small-Cell Lung Cancer
9. Novel Technique For Management Of Inverted Papilloma Of Frontal Sinus
10. New Cardiac Angiography Technique For Improved Imaging Of Coronary Veins
11. New Technique Enables Better Nursing Of Robin Sequence Infants
Post Your Comments:
(Date:7/25/2008)...liance to be presented at Fenway Park ...y 25 /PRNewswire/ -- CVS/pharmacy announced today,...4 million in just 21 days,through its annual in-st...,the seventh year of the annual fundraising effort...for ALS research. This year,s fundraiser took,plac...
(Date:7/25/2008)...gus can cause immune system changes , , ...ence linking gastroesophageal reflux disease (GERD...y Medical Center researchers. , An association ...1970s, and since then studies have shown that betw...lso experience GERD symptoms. But the actual link ...
(Date:7/25/2008)...am delivers immediate cost savings for http://www...to language interpreters] to firms switching lang... , Washington, D.C. (Vocu...nc.com/index.html [(Language Learning Enterprises...anslation, and language instruction services to th...
(Date:7/25/2008)...ou are an Olympian, Professional Athlete, Elite Am...u Need to Know about Hydration to Boost Sports Per...r , Marina del Rey, Calif...tes are heading to Beijing following years of inte...pes of capturing an Olympic medal and securing the...
Breaking Medicine News(10 mins):Health News:CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign 2Health News:People With GERD More Likely to Develop Asthma 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 4Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 5
... that she feared that her recent miscarriage was g...he 25-year-old, who lost her baby when she was thr...coping with bad times since the beginning of this ...ould never recover after losing the baby. "After ...
...man's performance in the bedroom, but as researche... function . This finding means that the popular d...ially save the lives of people with specific heart...was conducted by researchers at the University of ...
...l of Medicine in St. Louis have developed the firs... hoping it will help explain why the success of th...organ transplants. Ultimately, the mouse model co...therapies to prevent lung transplant rejection a ...
...as admitted that she fears that an innocent kiss w...ner said that she has major trust issues, and that...e of it, for it is a waste of her time and kisses....e is also scared of ending up having 'mouth herpes...
Other Medicine News:Health News:Viagra Improves Heart Function, Finds Study 2Health News:Viagra Improves Heart Function, Finds Study 3Health News:Researchers Develop First Mouse Model of Lung Transplantation 2Health News:Researchers Develop First Mouse Model of Lung Transplantation 3Health News:Researchers Develop First Mouse Model of Lung Transplantation 4
(Date:7/22/2008)...er 293-patient European, trial -, http://www.cr... MONTREAL, July 22 / CryoCa...therapy products to treat cardiac,arrhythmias, tod...m three,European study centers using the Company,s...lier today in the Journal of the American College ...
(Date:7/22/2008)...t Initiative bring MJFF,s,current active industry ...09, NEW YORK, July 22 /PRNewswire-USNewswire/ -- ...ormative treatments and a cure for Parkinson,s,dis...s Research has awarded,$2.7 million in total fundi... granted under MJFF,s Therapeutics Development Ini...
(Date:7/22/2008)...of Treating Patients with ...SI, South Korea, July 22 /-,Jennerex,... its South,Korean partner Green Cross Corp., annou...ical trial of its first-in-class lead product JX-5...d and resulted in clear,anti-cancer efficacy in pa...
(Date:7/22/2008)...R) Resulted in Significant, Reductions in A1C in P...hm Used, BRIDGEW...he "Adjust to,Target in Type 2 Diabetes: Compariso...or Adjustment of Mealtime Insulin Glulisine" study...ion,s (ADA) medical journal,Diabetes Care. This s...
Breaking Medicine Technology:CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4Administration Anesthetized to Ailments of Nations Children 4103 1Cognizant to Acquire marketRx a Leading Provider of Life Sciences Market Analytics 1358 1Cognizant to Acquire marketRx a Leading Provider of Life Sciences Market Analytics 1358 2Cognizant to Acquire marketRx a Leading Provider of Life Sciences Market Analytics 1358 3Cognizant to Acquire marketRx a Leading Provider of Life Sciences Market Analytics 1358 4Coherent Inc to Webcast Fourth Fiscal Quarter 2007 Results 1355 1Video 3A Trinity Mother Frances Neurosurgeon Using New Disc System for Patients With Degenerative Diseases of the Neck 1352 1Video 3A Trinity Mother Frances Neurosurgeon Using New Disc System for Patients With Degenerative Diseases of the Neck 1352 2
...tion in Intestinal Adenomas Suggesting,Possible Be...,Cancer, EL DORADO HILLS, Calif., March 07, 2007 /...s of a study on the effect of rice bran,on the num...ished,in the January 9, 2007 online edition of the...t the Department of Cancer Studies and,Molecular M...
...of Higher Doses to Further Reduce Antibodies,to Do...wswire-FirstCall/ -- La Jolla,Pharmaceutical Compa...ts from its ongoing double-blind, placebo-controll...s sodium), its drug,candidate for systemic lupus e...im antibody data indicate that patients treated,wi...
Other Medicine Technology:British Journal of Cancer Reports Preclinical Evidence of Positive,Effect of Rice Bran on Intestinal Cancer 2British Journal of Cancer Reports Preclinical Evidence of Positive,Effect of Rice Bran on Intestinal Cancer 3British Journal of Cancer Reports Preclinical Evidence of Positive,Effect of Rice Bran on Intestinal Cancer 4La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 2La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 3La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 4La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 5La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 6La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 7
The NOW® Malaria Test is a field or laboratory test for the differential diagnosis of a Malaria infection. It is intended for the detection of circulating Plasmodium falciparum (P.f.) antigen
Ultraview 1700 Central Monitor
...tient Care Monitor (PCM) and Central Station provi...PCM extends the cardiac cath or electrophysiology ...ath and/or EP procedures, providing both physiomon...device either standalone or on its own network. W...
...nitoring via the Acuity central station and Welch ...nvert non-monitored beds into centrally monitored ...t both wireless and hardwired monitors and clinica...ities from a community hospital to a teaching inst...
Medicine Products: